All chemicals, including anhydrous solvents, were purchased from Sigma Aldrich and used without further purification, unless otherwise noted. Deuterated solvents for NMR spectroscopy were purchased from Cambridge Isotopes Laboratories. NMR spectra were recorded on a Bruker Advance III 400 MHz spectrometer at the UCSF NMR lab, and spectra were analyzed using Mestrelab software. High resolution mass spectra were recorded on a Bruker microTOF II at the University of Notre Dame's Mass Spectrometry and Proteomics core facility. Fluorine-18 was obtained as a NaF salt from the cyclotron core at UCSF.
Synthetic methods for Gr01 and Gr02
To a solution of 3-bromopropanol (10 mL, 114 mmol, 1 eq.) in anhydrous tetrahydrofuran (100 mL) was added tert-butyl-dimethylsilyl chloride (22.2 g, 149 mmol, 1.3 eq.) followed by imidazole (23.2 g, 343 mmol, 3 eq.)
The reaction was stirred at room temperature for 24 hours under argon (g). The reaction was concentrated under reduced pressure and resuspended in water (100 mL) and extracted with dichloromethane (3 × 20 mL). The organic portions were combined, washed with brine (60 mL), dried over Na 2 SO 4 , filtered, and concentrated under reduced pressure to afford 3-bromopropyl-tertbutyldimethylsilyl ether as a clear and colorless oil (28 g, 110 mmol, 97% yield).
1 H NMR (CDCl 3 ): d 0.06 (s, 6H); 0.89 (s, 9H); 1.99-2.07 (m, 2H); 3.51 (t, 2H, J = 3.2 Hz); 3.73 (t, 2H, J = 2.8 Hz).
To a solution of prednisolone (1.5 g, 4.16 mmol, 1 eq.) in a 1:1 mixture of 3-bromopropyl-tertbutyldimethylsilyl ether (4 mL, 10 eq) and anhydrous dimethyl formamide (4 mL) was added freshly pulverized KOH (700 mg, 12.5 mmol, 3 eq.). The reaction was stirred at 70° C for 4 hours under argon (g). The reaction was diluted with ethyl acetate (80 mL) and washed with saturated NH 4 Cl (aq) solution (5 × 20 mL), washed with brine (1 × 20 mL), dried over Na 2 SO 4 , filtered, and concentrated under reduced pressure. The residue was purified by silica chromatography (hexanes:ethyl acetate) to afford 2 as a white solid (798 mg, 1.5 mmol, 36% yield). To a solution of 2 (750 mg, 1.4 mmol, 1 eq.) in tetrahydrofuran (14 mL) was added 1M tetra-butyl ammonium fluoride solution (1.8 mL, 1.8 mmol, 1.3 eq.). The reaction was stirred at room temperature for 8 hours. The reaction with concentrated under reduced pressure and passed through a silica plug to afford 3 as a white solid (580 mg, 1.39 mmol, 99% yield). To a solution of 3 (42 mg, 100 mmol, 1 eq.) in anhydrous dichloromethane (1 mL) was added methanesulfonyl chloride (15.5 mL, 200 mmoles, 2 eq.) followed by triethylamine (42 mL, 300 mmoles, 3 eq.). The reaction was stirred at room temperature for 2 hours. The reaction was diluted with ethyl acetate (10 mL) and washed with 1M HCl (aq.) solution (3 × 2 mL), washed with brine (1 × 2 mL), dried over Na 2 SO 4 , filtered, concentrated to afford 4 as a white solid (40 mg, 80 mmoles, 80% yield). Compound 4 was used without any further purification.
To a solution of 4 (40 mg, 80 mmol, 1 eq.) in anhydrous tetrahydrofuran (1.6 mL) was added 1M tetrabutyl ammonium fluoride solution (104 mL, 104 mmol, 1.3 eq.). The reaction was stirred at room temperature for 8 hours. The reaction with concentrated under reduced pressure and purified by silica chromatography (hexanes:ethyl acetate) to afford 5 as a white solid (24 mg, 58 mmol, 72% yield). To a solution of fluorobenzoic acid (1.4 g, 10 mmol, 1 eq.) and N-hydroxysuccinimide (1.27 g, 11 mmol, 1.1 eq.) in anhydrous N-methyl-2-pyrrolidone (30 mL) was added N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (2.3 g, 12 mmol, 1.2 eq.) followed by N,Ndiisopropylethylamine (3.5 mL, 20 mmol, 2 eq.). The reaction was stirred at room temperature for 2 hours. The reaction was diluted with ethyl acetate (300 mL) and washed with 1M HCl (aq) solution (3 × 60 mL), washed with brine (1 × 60), dried over Na 2 SO 4 , filtered, concentrated to afford N-succinimidyl-4-fluorobenzoate as a white solid (2.1 g, 8.9 mmol, 89% yield).
1 H NMR (400 MHz, CDCl 3 ) d (ppm) 2.9 (s, 4H); 7.2 (m, 2H); 8.1 (m, 2H). The identity of the product was verified by comparing the 1 H NMR data to the spectrum previously reported in the literature [1] .
The C21 primary alcohol on prednisolone was converted to a methanesulfonyl ester following a previously described protocol [2] . To a solution of prednisolone (1.5 g, 4.16 mmol, 1 eq.) in pyridine (10 mL) at 0° C was added methanesulfonyl chloride (1.5 mL, 19.4 mmol, 4.7 eq.). The reaction was stirred for 2 hours at 0° C. The reaction was added dropwise to a rapidly stirring solution of ice water (100 mL) and stirring was continued until the ice completely melted. The solution was filtered under reduced pressure and the collected precipitate was washed with cold water and dried overnight under high vacuum.
The white solid was suspended in methyl acetate (40 mL) and NaI (2.5 g, 16.6 mmol, 4 eq.) was added followed by NaN 3 (1.35 g, 20.8 mmol, 5 eq.). The reaction was stirred at 60° C overnight. The reaction was added dropwise to a rapidly stirring solution of ice water (400 mL) and stirring was continued until the ice completely melted. The solution was filtered under reduced pressure and the collected precipitate was washed with cold water and dried overnight under high vacuum to afford 6 as a tan solid (1.43 g, 3.7 mmol, 89% yield). To a solution of 6 (1 g, 2.6 mmol, 1 eq.) and ditertbutyl-dicarbonate (1.1 g, 5.2 mmol, 2 eq.) in anhydrous methanol (13 mL) was added Lindlar catalyst (200 mg, 20% by wt.). The reaction was evacuated and sparged with H 2 (g) thrice and stirred at room temperature for 12 hours under 1 atm of H 2 (g). The reaction was concentrated onto Celite TM and purified by silica chromatography (hexanes:ethyl acetate) to afford 7 as a white solid (735 mg, 1.6 mmol, 61% yield). To a solution of 7 (700 mg, 1.5 mmol) in anhydrous dichloromethane (7.5 mL) was added trifluoroacetic acid (7.5 mL). The reaction was stirred for 3 hours at room temperature. The reaction was concentrated under reduced pressure to afford 8 as a white solid (710 mg, 1.5 mmol, 99%). To a solution of 8 (47 mg, 100 mmol, 1 eq.) in N-methyl-pyrrolidone (1 mL) was added N-succinimidyl-4-fluorobenzoate (26 mg, 110 mmol, 1.1 eq.) followed by N,Ndiisopropylethylamine (35 mL, 200 mmol, 2 eq.). The reaction was stirred at room temperature for 8 hours. The reaction was diluted with ethyl acetate (10 mL) and washed with 1M HCl (aq) solution (3 × 2 mL), washed with brine (1 × 2 mL), dried over Na 2 SO 4 , filtered, and concentrated under reduced pressure. The residue was purified by silica chromatography (Hexanes:ethyl acetate) to afford 9 as a white solid (40 mg, 83 mmol, 83%). 
F-Gr01
[ 18 F]-fluoride anion (3.7-18.5 GBq) was eluted off a QMA Sep-Pak cartridge using 0.5 mL of a K 2.2.2 /KHCO 3 solution (11 mg/mL of K 2.2.2 , 1 mg/mL of K 2 CO 3 , 9:1 v:v acetonitrile:H 2 O). The resulting solution was subjected to 3 drying cycles at 115°C under a gentle stream of nitrogen. Compound 4 (~5 mg) was dissolved in anhydrous DMSO (800 mL) and added to [
18 F]-fluoride, and the resulting solution was sealed and heated at 130° C for 20 min.
18
F-GR01 was isolated via semi-preparative reverse phase-HPLC coupled to a radiation detector (5%-95% gradient of acetonitrile in H 2 O with 0.1% formic acid.) The product fraction isolated off of the HPLC was diluted to ~30 mL in H 2 O and loaded onto a C18-light Sep-Pak cartridge. The product fraction isolated off of the HPLC was diluted to ∼30 mL in H 2 O and loaded onto a C18-light Sep-Pak cartridge preconditioned with ethanol (5 mL) and H 2 O (5 mL). The cartridge was washed with 10 mL H 2 O and the activity was eluted with ethanol (500 µL). The resulting solution was then concentrated for 1 h at 50° C under reduced pressure, and 18 F-GR02 was then dissolved in a solution of 15% ethanol (aq.) for animal studies. The radiotracer was confirmed to be >99% radiochemical purity prior to administration in animals. F-GR02 was isolated via semi-preparative reverse phase-HPLC coupled to a radiation detector (20-60% gradient of acetonitrile in H 2 O with 0.1% formic acid). The product fraction isolated off of the HPLC was diluted to ∼30 mL in H 2 O and loaded onto a C18-light Sep-Pak cartridge. The Sep-Pak cartridge was washed with ethanol (5 mL) and H 2 O (5 mL), and then the collected activity was added onto the Sep-Pak cartridge and was washed with 10 mL H 2 O and the activity was eluted with ethanol (0.5 µL). The resulting solution was then concentrated for 1 h at 50° C under reduced pressure, and 18 F-GR02 was then dissolved in a solution of 15% ethanol (aq.) for animal studies. The radiotracer was >99% pure prior to administration in animals.t
